GLP-1 Drugs and Hair Loss: Why It Happens and How to Manage It
Hair thinning is a common and distressing side effect for some GLP-1 users. Here is the science behind why it happens, when it peaks, and practical ways to reduce it.
Hair thinning is one of the more distressing side effects some GLP-1 users experience. It is listed in the prescribing information for both Wegovy and Zepbound, and it is something that appears regularly in patient discussions about semaglutide and tirzepatide.
Understanding why it happens helps reduce anxiety and leads to better practical responses.
What type of hair loss is this?
In most cases, GLP-1-related hair thinning is a condition called telogen effluvium. It is not the same as pattern baldness or alopecia areata.
In telogen effluvium:
- Physical or metabolic stress signals hair follicles to shift from the growth phase to the resting phase simultaneously
- 2–4 months later, those hairs shed
- The follicles are not damaged - they regrow over the following 6–12 months
- The shedding looks dramatic (lots of hair in the shower, on the pillow) but is usually temporary
This pattern is also seen after significant surgery, major illness, childbirth, extreme dieting, and rapid weight loss from any cause. The GLP-1 medication itself may not be the direct trigger - the rapid caloric restriction and weight loss it enables is.
Why does rapid weight loss trigger hair shedding?
Fast calorie reduction and weight loss can create nutritional shortfalls even when a person is eating reasonably. The most common contributors:
Insufficient protein
When calorie intake drops sharply (a common early effect of GLP-1 medications), protein intake often falls with it. Hair follicles are almost entirely protein (keratin). Inadequate protein is one of the most consistent triggers of telogen effluvium.
Low iron or ferritin
Iron deficiency is strongly associated with hair thinning, particularly in women. Calorie restriction can reduce iron intake, and low ferritin levels are often found in people experiencing hair loss on GLP-1 therapy.
Zinc and biotin deficiency
Both are involved in hair follicle health. Deficiencies are more common during periods of rapid weight loss.
Physiological stress signal
Beyond specific nutrients, the body registers rapid weight loss as a form of stress and responds by redirecting resources away from non-essential functions - including hair growth.
When does it peak and resolve?
The typical pattern:
- Starts: 2–4 months after beginning medication or a significant dose increase
- Peaks: around month 4–6
- Resolves: gradual regrowth over 6–12 months as weight loss stabilises
Hair shedding that continues beyond 6 months, or that is accompanied by other symptoms, should be discussed with a doctor to rule out other causes.
Practical steps to reduce the risk
You cannot always prevent telogen effluvium, but these strategies help:
1. Prioritise protein
Aim for at least 1.2–1.6 g of protein per kg of body weight daily. This is higher than typical dietary guidance but important during active weight loss. Good sources include eggs, fish, poultry, legumes, Greek yoghurt, and whey protein.
2. Do not crash your calories
GLP-1 medications suppress appetite significantly. Some patients eat far too little, especially early on. Aim to stay above 1,200 kcal for women and 1,500 kcal for men at minimum.
3. Check your bloodwork
Ask your doctor to check ferritin (not just haemoglobin), zinc, and vitamin D. Correcting deficiencies early can reduce the severity of shedding.
4. Use a gentle hair care routine
Avoid heat styling, tight hairstyles, and harsh chemical treatments during periods of active shedding. These do not cause the underlying problem but can increase breakage.
5. Consider a consultation with a dermatologist
If shedding is significant, a dermatologist can assess whether topical treatments (such as minoxidil) are appropriate or whether a different underlying cause needs investigation.
Tracking side effects consistently
Hair thinning typically correlates with the fastest phase of weight loss. If you are tracking your dose changes, weight trend, and symptom patterns week by week, you can see that connection clearly - and report it accurately to your doctor.
Final takeaway
Hair thinning on GLP-1 medications is usually telogen effluvium - a temporary shedding triggered by rapid weight loss and nutritional stress, not permanent follicle damage. The most effective response is maintaining adequate protein intake, avoiding extreme calorie restriction, and monitoring for nutrient deficiencies. In most cases, hair density recovers as weight loss stabilises.
Consult your healthcare provider if you experience significant or prolonged hair loss.
Sources
- Wegovy (semaglutide) prescribing information - Novo Nordisk
- Zepbound (tirzepatide) prescribing information - Eli Lilly
- Asghar F, et al. Telogen effluvium: a review of the literature. Cureus. 2020;12(5)
- Almohanna HM, et al. The role of vitamins and minerals in hair loss. Dermatol Ther. 2019;9(1):51–70
FAQ
Does Ozempic cause hair loss?
Hair thinning is listed as a side effect for Wegovy (semaglutide) and Zepbound (tirzepatide). It occurs in a minority of users, typically during rapid weight loss. The condition is usually telogen effluvium - a temporary shedding triggered by physical stress - not permanent hair follicle damage.
Is hair loss from GLP-1 drugs permanent?
In most cases, no. Hair thinning from telogen effluvium is temporary. Shedding typically peaks 2–4 months after the triggering stress and regrows over 6–12 months as the body stabilises.
How do I prevent hair loss on Ozempic or Mounjaro?
You cannot always prevent it, but you can reduce the risk. Key strategies include maintaining adequate protein intake (at least 1.2–1.6 g per kg of body weight), avoiding crash-level calorie restriction, addressing nutritional deficiencies (especially iron and zinc), and managing the rate of weight loss.
When does hair loss from GLP-1 drugs start?
Typically 2–4 months after starting the medication or after a significant dose increase. It often coincides with the period of fastest weight loss.